184 related articles for article (PubMed ID: 14729797)
1. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
Huang Y; Salu K; Liu X; Li S; Wang L; Verbeken E; Bosmans J; De Scheerder I
Heart; 2004 Feb; 90(2):195-9. PubMed ID: 14729797
[TBL] [Abstract][Full Text] [Related]
2. Stent-mediated methylprednisolone delivery reduces macrophage contents and in-stent neointimal formation.
Wang L; Salu K; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I; Huang Y
Coron Artery Dis; 2005 Jun; 16(4):237-43. PubMed ID: 15915076
[TBL] [Abstract][Full Text] [Related]
3. Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.
Salu KJ; Huang Y; Bosmans JM; Liu X; Li S; Wang L; Verbeken E; Bult H; Vrints CJ; De Scheerder IK
Coron Artery Dis; 2003 Dec; 14(8):545-55. PubMed ID: 14646676
[TBL] [Abstract][Full Text] [Related]
4. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
[TBL] [Abstract][Full Text] [Related]
5. Polymer stent coating for prevention of neointimal hyperplasia.
Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
[TBL] [Abstract][Full Text] [Related]
6. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
[TBL] [Abstract][Full Text] [Related]
7. Stent-based tempamine delivery on neointimal formation in a porcine coronary model.
Huang Y; Wang L; Li S; Liu X; Lee K; Verbeken E; van de Werf F; de Scheerder I
Acute Card Care; 2006; 8(4):210-6. PubMed ID: 17162547
[TBL] [Abstract][Full Text] [Related]
8. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.
Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ
Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559
[TBL] [Abstract][Full Text] [Related]
9. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.
Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I
Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906
[TBL] [Abstract][Full Text] [Related]
10. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
11. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
[TBL] [Abstract][Full Text] [Related]
12. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
13. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.
Suzuki T; Kopia G; Hayashi S; Bailey LR; Llanos G; Wilensky R; Klugherz BD; Papandreou G; Narayan P; Leon MB; Yeung AC; Tio F; Tsao PS; Falotico R; Carter AJ
Circulation; 2001 Sep; 104(10):1188-93. PubMed ID: 11535578
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model.
Hong MK; Kornowski R; Bramwell O; Ragheb AO; Leon MB
Coron Artery Dis; 2001 Sep; 12(6):513-5. PubMed ID: 11696691
[TBL] [Abstract][Full Text] [Related]
15. Stent coating with titanium-nitride-oxide for reduction of neointimal hyperplasia.
Windecker S; Mayer I; De Pasquale G; Maier W; Dirsch O; De Groot P; Wu YP; Noll G; Leskosek B; Meier B; Hess OM;
Circulation; 2001 Aug; 104(8):928-33. PubMed ID: 11514381
[TBL] [Abstract][Full Text] [Related]
16. Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model.
Yoon JH; Wu CJ; Homme J; Tuch RJ; Wolff RG; Topol EJ; Lincoff AM
Yonsei Med J; 2002 Apr; 43(2):242-51. PubMed ID: 11971219
[TBL] [Abstract][Full Text] [Related]
17. [Effects of controlled-release arsenic-trioxide-eluting stents on in-stent neointimal hyperplasia in coronary artery: experiment with dog model].
Zhao JL; Sun BG; Wen QZ; Zhang JJ; Jin W; Xue JX; Zhuang WY
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):567-9. PubMed ID: 17459213
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
[TBL] [Abstract][Full Text] [Related]
19. Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries.
Matsumoto Y; Shimokawa H; Morishige K; Eto Y; Takeshita A
J Cardiovasc Pharmacol; 2002 Apr; 39(4):513-22. PubMed ID: 11904525
[TBL] [Abstract][Full Text] [Related]
20. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents.
Huang Y; Wang L; Verweire I; Qiang B; Liu X; Verbeken E; Schacht E; De Scheerder I
J Invasive Cardiol; 2002 Sep; 14(9):505-13. PubMed ID: 12205348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
